Publications

Selected Publications 

Dimitri AJ, Baxter AE, Chen GM, Hopkins CR, Rouin GT, Huang H, Kong W, Holliday CH, Wiebking V, Bartoszek R, Drury S, Dalton K, Koucky OM, Chen Z, Giles JR, Dils AT, Jung IY, O'Connor R, Collins S, Everett JK, Amses K, Sherrill-Mix S, Chandra A, Goldman N, Vahedi G, Jadlowsky JK, Young RM, Melenhorst JJ, Maude SL, Levine BL, Frey NV, Berger SL, Grupp SA, Porter DL, Herbst F, Porteus MH, Carty SA, Bushman FD, Weber EW, Wherry EJ, Jordan MS, Fraietta JA. TET2 regulates early and late transitions in exhausted CD8+ T cell differentiation and limits CAR T cell function. Sci Adv. 2024 Nov 15. PMID: 39536093 

Correa-Medero LO, Jankowski, SE, Hong HS, Armas NA, Vijedra AI, Reynolds MB, Fogo GM, Awad D, Dils AT, Inoki KA, Williams RG, Ye AM, Svezhova N, Gomez-Rivera F, Collins KL, O'Riordan MX, Sanderson TH, Lyssiotis CA, Carty SA. ER-associated degradation adaptor Sel1L is required for CD8+ T cell function and memory formation following acute viral infection. Cell Reports. 2024 May 28. PMID: 3868742.

Biological insights into the role of TET2 in T cell lymphomas. Carty SA. Front Oncol. 2023 Sep 29;13:1199108.  PMID: 37841428 

Metabolomic Profiles of Human Glioma Inform Patient Survival. Scott AJ, Correa LO, Edwards DM, Sun Y, Ravikumar V, Andren AC, Zhang L, Srinivasan S, Jairath N, Verbal K, Muraszko K, Sagher O, Carty SA, Hervey-Jumper S, Orringer D, Kim MM, Junck L, Umemura Y, Leung D, Venneti S, Camelo-Piragua S, Lawrence TS, Ippolito JE, Al-Holou WN, Chinnaiyan P, Heth J, Rao A, Lyssiotis CA, Wahl DR. Antioxid Redox Signal. 2023 Nov;39(13-15):942-956. PMID: 36852494 

OXPHOS promotes apoptotic resistance and cellular persistence in TH17 cells in the periphery and tumor microenvironment. Hong HS, Mbah NE, Shan M, Loesel K, Lin L, Sajjakulnukit P, Correa LO, Andren A, Lin J, Hayashi A, Magnuson B, Chen J, Li Z, Xie Y, Zhang L, Goldstein DR, Carty SA, Lei YL, Opipari AW, Argüello RJ, Kryczek I, Kamada N, Zou W, Franchi L, Lyssiotis CA. Sci Immunol. 2022 Nov 25;7(77). PMID: 36399539 

Immunology 101: fundamental immunology for the practicing hematologist. Carty SA. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):281-286. PMID: 34889423

Correa LO, Jordan MS, Carty SA. DNA Methylation in T-Cell Development and Differentiation. Critical Rev Immuno 2020;40(2):135-156. PMID: 32749092

Fraietta JA, Nobles CL, Sammons MA, Lundh S, Carty SA, et al.: Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 2018 Jun;558(7709):307-312 PMID: 29849141 

Carty SA, Gohil M, Banks LB, Cotton RM, Johnson ME, Stelekati E, Wells AD, Wherry EJ, Koretzky GA, Jordan MS. The Loss of TET2 Promotes CD8 T Cell Memory + Differentiation. J Immunol 200(1): 82-91, 01/2018. PMID: 29150566 

Prince AL, Kraus Z, Carty SA, Ng C, Yin CC, Jordan MS, Schwartzberg PL, Berg LJ: Development of innate CD4+ and CD8+ T cells in Itk-deficient mice is regulated by distinct pathways. J Immunol 193(2): 688-99, 01/2014. PMID: 24943215 

Carty SA, Koretzky GA, Jordan MS: Interleukin-4 regulates eomesodermin in CD8+ T cell development and differentiation. PLoS One 9(9): e106659, 01/2014. PMID: 25207963

Gordon SM*, Carty SA*, Kim JS, Zou T, Smith-Garvin J, Alonzo ES, Haimm E, Sant'Angelo DB, Koretzky GA, Reiner SL, Jordan MS: Requirements for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-like CD8+ T cells. J Immunol 186(8): 4573-8, 01/2011. PMID: 21383242 *co-first authors